Literature DB >> 29480345

Atrial fibrillation and its pernicious role in heart failure with preserved ejection fraction: a new frontier in interventional electrophysiology.

Sanjeev Saksena1,2, April Slee3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29480345     DOI： 10.1007/s10840-018-0341-3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  17 in total

1.  Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Authors:  Marc A Pfeffer; Brian Claggett; Susan F Assmann; Robin Boineau; Inder S Anand; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; John F Heitner; Eldrin F Lewis; Eileen O'Meara; Jean-Lucien Rouleau; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Sonja M McKinlay; Bertram Pitt
Journal:  Circulation       Date:  2014-11-18       Impact factor: 29.690

2.  Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.

Authors:  Scott D Solomon; Brian Claggett; Eldrin F Lewis; Akshay Desai; Inder Anand; Nancy K Sweitzer; Eileen O'Meara; Sanjiv J Shah; Sonja McKinlay; Jerome L Fleg; George Sopko; Bertram Pitt; Marc A Pfeffer
Journal:  Eur Heart J       Date:  2015-09-15       Impact factor: 29.983

3.  Spironolactone for heart failure with preserved ejection fraction.

Authors:  Bertram Pitt; Marc A Pfeffer; Susan F Assmann; Robin Boineau; Inder S Anand; Brian Claggett; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Brian Harty; John F Heitner; Christopher T Kenwood; Eldrin F Lewis; Eileen O'Meara; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Song Yang; Sonja M McKinlay
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

4.  Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Authors:  Lars G Olsson; Karl Swedberg; Anique Ducharme; Christopher B Granger; Eric L Michelson; John J V McMurray; Margareta Puu; Salim Yusuf; Marc A Pfeffer
Journal:  J Am Coll Cardiol       Date:  2006-04-27       Impact factor: 24.094

5.  Assessment of atrial regional wall motion using strain Doppler imaging during biatrial pacing in the bradycardia-tachycardia syndrome.

Authors:  Katsumi Matsumoto; Toshiyuki Ishikawa; Shinichi Sumita; Kohei Matsushita; Noriko Inoue; Tsukasa Kobayashi; Kazuaki Uchino; Kazuo Kimura; Satoshi Umemura
Journal:  Pacing Clin Electrophysiol       Date:  2006-03       Impact factor: 1.976

6.  Dual site right atrial pacing can improve the impact of standard dual chamber pacing on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: further observations from the dual site atrial pacing for prevention of atrial fibrillation trial.

Authors:  Atul Prakash; Sanjeev Saksena; Paul D Ziegler; Tasneem Lokhandwala; Douglas A Hettrick; Phillipe Delfaut; Navin C Nanda; D George Wyse
Journal:  J Interv Card Electrophysiol       Date:  2005-04       Impact factor: 1.900

7.  Left atrial reverse remodeling and prevention of progression of atrial fibrillation with atrial resynchronization device therapy utilizing dual-site right atrial pacing in patients with atrial fibrillation refractory to antiarrhythmic drugs or catheter ablation.

Authors:  Rangadham Nagarakanti; April Slee; Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2014-07-31       Impact factor: 1.900

8.  Catheter Ablation for Atrial Fibrillation with Heart Failure.

Authors:  Nassir F Marrouche; Johannes Brachmann; Dietrich Andresen; Jürgen Siebels; Lucas Boersma; Luc Jordaens; Béla Merkely; Evgeny Pokushalov; Prashanthan Sanders; Jochen Proff; Heribert Schunkert; Hildegard Christ; Jürgen Vogt; Dietmar Bänsch
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

9.  History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.

Authors:  Oludamilola W Oluleye; Thomas S Rector; Sithu Win; John J V McMurray; Michael R Zile; Michel Komajda; Robert S McKelvie; Barry Massie; Peter E Carson; Inder S Anand
Journal:  Circ Heart Fail       Date:  2014-09-15       Impact factor: 8.790

Review 10.  Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.

Authors:  Dipak Kotecha; Carolyn S P Lam; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Adriaan A Voors; Michiel Rienstra
Journal:  J Am Coll Cardiol       Date:  2016-11-15       Impact factor: 24.094
View more
  1 in total

Review 1.  Treatment of atrial fibrillation: a comprehensive review and practice guide.

Authors:  Jianhua Li; Mei Gao; Minwei Zhang; Donglu Liu; Zhan Li; Juanjuan Du; Yinglong Hou
Journal:  Cardiovasc J Afr       Date:  2020-03-18       Impact factor: 1.167
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.